These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2900545)

  • 1. [Value of oral premedication with a non-sedative anxiolytic agent for performing electrophysiological hearing tests. Apropos of 100 cases of patients treated with bromazepam].
    Portmann M; Négrevergne M; Chène C; Cros AM; Paty J; Berthomieu J
    Rev Laryngol Otol Rhinol (Bord); 1988; 109(2):155-9. PubMed ID: 2900545
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Royal College of General Practitioners Medicines Surveillance Organisation
    J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
    Sonne LM; Bruun-Hansen J
    Ugeskr Laeger; 1986 Jun; 148(23):1392-5. PubMed ID: 2873673
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromazepam ('Lexotanil') compared with placebo: a double-blind, crossover study.
    Rey A; Bovet J; Schneider PB
    Pharmatherapeutica; 1984; 4(1):13-20. PubMed ID: 6150491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment].
    Fynboe C; Christensen N; Halberg T; Hansen EA; Holm P; Knudsen JP; Lindhardt J; Maul B; Musaeus C; Nielsen MT; Schaumburg E
    Ugeskr Laeger; 1981 Oct; 143(41):2641-5. PubMed ID: 6117963
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bromazepam versus placebo. Double-blind crossover study].
    Rey A; Bovet J; Schneider PB
    Schweiz Rundsch Med Prax; 1984 Jan; 73(5):143-8. PubMed ID: 6142517
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical trial of bromazepam (author's transl)].
    Laxenaire M; Kahn JP; Marchand P
    Nouv Presse Med; 1982 May; 11(22):1699-701. PubMed ID: 6124936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anxiety in ambulatory and hospital practice: effects of a new anxiolytic agent, bromazepam, in a homogeneous series of 30 patients (author's transl)].
    Billé J; Dalmas C
    Nouv Presse Med; 1982 May; 11(22):1706-9. PubMed ID: 6124938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of anxiety in Parkinson's disease with bromazepam].
    Casacchia M; Zamponi A; Squitieri G; Meco G
    Riv Neurol; 1975; 45(3):326-38. PubMed ID: 7014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bromazepam in the treatment of anxiety in nephrology and haemodialysis (author's transl)].
    Schohn D; Schmitt R; Jahn H
    Nouv Presse Med; 1982 May; 11(22):1718-21. PubMed ID: 6124941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bromazepam in anxiety. Clinical evaluation (author's transl)].
    Perret J; Zagala A; Gaio JM; Hommel M; Meaulle F; Pellat J; Pollak P
    Nouv Presse Med; 1982 May; 11(22):1722-4. PubMed ID: 6124942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of depressive disorders. Clinical evaluation of the relative effectiveness of flupenthixol in comparison with bromazepam].
    Paulmann F
    Fortschr Med; 1986 Mar; 104(10):218-22. PubMed ID: 2870960
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the therapeutic effect of bromazepam and chlorprothixene in depressive neuroses].
    Zapletálek M; Kudrnová K; Preiningerová O; Zapletálková J
    Cesk Psychiatr; 1982 Dec; 78(6):375-81. PubMed ID: 6129927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with the benzodiazepine derivative bromazepam in acute agitation and excitement conditions in psychiatry].
    Gsell S
    Nervenarzt; 1975 Aug; 46(8):463-6. PubMed ID: 4740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of bromazepam. Thirty cases (author's transl)].
    Sechter D; Petitjean F; Bitoun G
    Nouv Presse Med; 1982 May; 11(22):1744-6. PubMed ID: 6124949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and therapeutic approach to anxiety-depression syndromes. Effectiveness of bromazepam (author's transl)].
    Dachary JM; Rousseau C
    Nouv Presse Med; 1982 May; 11(22):1710-2. PubMed ID: 6124939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of psychoautonomic disorders. Clinical double-blind duplex study with dipotassium chlorazepate and bromazepam].
    Heller H; Steger W
    MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):715-7. PubMed ID: 6138710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anxiety states and bromazepam (author's transl)].
    Ferreri M; Alby JM
    Nouv Presse Med; 1982 May; 11(22):1728-30. PubMed ID: 6124944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam].
    Lehmann E; Hassel P; Thörner GW; Karrass W
    Fortschr Med; 1984 Oct; 102(40):1033-6. PubMed ID: 6149989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.